Jjm. Smit et al., PERIPHERAL NEUROPATHY IN MICE TRANSGENIC FOR A HUMAN MDR3 P-GLYCOPROTEIN MINI-GENE, The Journal of neuroscience, 16(20), 1996, pp. 6386-6393
We have generated mice transgenic for a human MDR3 minigene, under con
trol of a hamster vimentin promoter. Expression of the MDR3 transgene
was found in mesenchymal tissues, peripheral nerves, and the eye lens.
These MDR3 transgenic mice have a slowed motor nerve conduction and d
ysmyelination of their peripheral nerves. An extensive dysmyelination
in some transgenic strains results in a severe peripheral neuropathy w
ith paresis of the hind legs. How expression of the MDR3 transgene cau
ses these abnormalities is unknown. The MDR3 gene encodes a large glyc
osylated plasma membrane protein with multiple transmembrane spanning
domains, which are involved in the translocation of the phospholipid p
hosphatidylcholine through the hepatocyte canalicular membrane. The ab
ility of the MDR3 P-glycoprotein to alter phospholipid distribution in
the plasma membrane of Schwann cells may cause the damage. It is also
possible, however, that the presence of a large glycoprotein in the c
ell membrane may be sufficient to severely disturb myelination of peri
pheral nerves.